User:Elizabeth Perkins: Difference between revisions
No edit summary |
No edit summary |
||
| Line 29: | Line 29: | ||
"Oncogenic BRAF in Tumor Initiation, Cancer Progression and Pathway-Targeted Therapy" | "Oncogenic BRAF in Tumor Initiation, Cancer Progression and Pathway-Targeted Therapy" | ||
11/30/2010 | 11/30/2010 | ||
| Line 34: | Line 37: | ||
"Modeling the Holoprosencephaly Spectrum in the Mouse: Regulation of Sonic Hedgehog Signaling by Co-Receptors" | "Modeling the Holoprosencephaly Spectrum in the Mouse: Regulation of Sonic Hedgehog Signaling by Co-Receptors" | ||
12/02/2010 | 12/02/2010 | ||
Shaomeng Wang, PhD | Shaomeng Wang, PhD | ||
Vollum Aditorium | Vollum Aditorium | ||
"Targeting Protein-Protein Interactions in the Apoptosis Pathwasys for New Cancer Therapeutics" | "Targeting Protein-Protein Interactions in the Apoptosis Pathwasys for New Cancer Therapeutics" | ||
12/14/2010 | 12/14/2010 | ||
| Line 45: | Line 51: | ||
"Hepatocyte Activities Revealed by Lineage and Differentiation Markers in Mice" | "Hepatocyte Activities Revealed by Lineage and Differentiation Markers in Mice" | ||
1/18/2011 | 1/18/2011 | ||
| Line 50: | Line 57: | ||
TBD | TBD | ||
2/15/2011 | 2/15/2011 | ||
| Line 55: | Line 63: | ||
TBD | TBD | ||
3/08/2011 | 3/08/2011 | ||
| Line 60: | Line 69: | ||
TBD | TBD | ||
3/29/2011 | 3/29/2011 | ||
| Line 65: | Line 75: | ||
TBD | TBD | ||
4/12/2011 | 4/12/2011 | ||
David Bentley, PhD | David Bentley, PhD | ||
TBD | TBD | ||
6/14/2011 | 6/14/2011 | ||
James Ford,MD | James Ford,MD | ||
Revision as of 15:43, 26 October 2010
- Knight Cancer Institute Seminar Series
- Charles Keller, MD Pediatric Cancer Biology Program
- c/o Elizabeth Perkins, Administrative Coordinator
- Oregon Health & Science University
- Pape'Family Pediatric Research Institute
- Mail Code: L321
- 3181 SW Sam Jackson Park Road
- Portland, OR 97239
- 503-494-9962
- perkinel@ohsu.edu
Objectives of the Knight Cancer Institute Seminar Series
The first annual Knight Cancer Institute Seminar series, co-sponsored by the Pediatric Cancer Biology program and the Knight Cancer Institute, will have a strong presence of childhood cancer basic and translational research topics presented by leading extramural scientists.
Knight Cancer Institute Seminar Series 2010-2011
- OHSU Main Hospital 8th Floor Conference Room 8B60
Tuesdays 4:00pm - 5:00pm
- Coordinator contact information: perkinel@ohsu.edu
Schedule
11/02/2010 Martin McMahon, PhD
"Oncogenic BRAF in Tumor Initiation, Cancer Progression and Pathway-Targeted Therapy"
11/30/2010
Robert S. Krauss, PhD
"Modeling the Holoprosencephaly Spectrum in the Mouse: Regulation of Sonic Hedgehog Signaling by Co-Receptors"
12/02/2010
Shaomeng Wang, PhD
Vollum Aditorium
"Targeting Protein-Protein Interactions in the Apoptosis Pathwasys for New Cancer Therapeutics"
12/14/2010
Edward E. Schmidt, PhD
"Hepatocyte Activities Revealed by Lineage and Differentiation Markers in Mice"
1/18/2011
Brian Rubin,MD, PhD
TBD
2/15/2011
John R. Ohlfest, PhD
TBD
3/08/2011
Amy Wagers,PhD
TBD
3/29/2011
William Stratford May
TBD
4/12/2011
David Bentley, PhD
TBD
6/14/2011 James Ford,MD
